Best Agrolife (539660) Q2 24/25 earnings summary

Executive summary

• Achieved strong Q2 and H1 FY25 performance with a strategic focus on branded products, innovation, and R&D, despite an 8% YoY revenue decline due to weather impacts and a shift in sales mix.

• Secured three key patents for innovative crop protection formulations in H1 FY25, reinforcing leadership in the patented segment.

• Branded business now accounts for 65% of revenue, with 35% YoY volume growth in Q2 FY25 and significant new product launches planned.

• Fully liquidated high-cost inventory, improving agility and operating cash flow, which rose to ₹1,251 million in H1 FY25 from ₹50.9 million YoY.

• Anticipates robust agricultural activity in H2 FY25 due to above-average rainfall and high water reservoir levels.

Financial highlights

• Q2 FY25 revenue from operations: ₹7,466 million (₹747 crore), down 8% YoY; H1 FY25: ₹12,659 million (₹1,266 crore), down from ₹1,423 crore in H1 FY24.

• Q2 FY25 EBITDA: ₹1,471 million (₹147 crore), margin improved to 19.7% (up 193 bps YoY); H1 FY25 EBITDA: ₹2,020 million (₹202 crore), margin at 16%.

• Q2 FY25 PAT: ₹947 million (₹95 crore), PAT margin at 12.7% (up 99 bps YoY); H1 FY25 PAT: ₹1,160 million (₹116 crore), margin at 9%.

• Diluted EPS for Q2 FY25 at ₹40.10; H1 FY25 EPS at ₹49.06.

• Net debt-to-equity improved to 0.59 as of September 2024 from 0.90 in March 2024.

Outlook and guidance

• Expects FY25 revenue growth of at least 15% and EBITDA margin of 15–17%; FY25 revenue expected to exceed ₹2,000 crore, with FY26 top-line growth targeted at 20%.

• Gross margins projected to rise further, driven by focus on patented and branded products.

• Plans to launch new patented herbicide ('Shot Down') and additional insecticides in Q3 and Q4 FY25.

• Focus on ramping up distribution, branded business, and improving cash flows and working capital cycle.